Tumor-derived microRNA-494 promotes angiogenesis in non-small cell lung cancer

[1]  Juan Wang,et al.  Expression and clinical evidence of miR-494 and PTEN in non-small cell lung cancer , 2015, Tumor Biology.

[2]  Hong Zhang,et al.  PPAR‐γ Promotes Endothelial Cell Migration By Inducing the Expression of Sema3g , 2015, Journal of cellular biochemistry.

[3]  Y. Akao,et al.  Colorectal cancer cell-derived microvesicles containing microRNA-1246 promote angiogenesis by activating Smad 1/5/8 signaling elicited by PML down-regulation in endothelial cells. , 2014, Biochimica et biophysica acta.

[4]  Yuhuang Li,et al.  miR‐494 acts as an anti‐oncogene in gastric carcinoma by targeting c‐myc , 2014, Journal of gastroenterology and hepatology.

[5]  You-Mie Lee,et al.  MicroRNA-382 induced by HIF-1α is an angiogenic miR targeting the tumor suppressor phosphatase and tensin homolog , 2014, Nucleic acids research.

[6]  Pengyuan Yang,et al.  Microenvironmental regulation of cancer metastasis by miRNAs. , 2014, Trends in cell biology.

[7]  E. Nkenke,et al.  miR-186, miR-3651 and miR-494: potential biomarkers for oral squamous cell carcinoma extracted from whole blood. , 2014, Oncology reports.

[8]  Aaron N. Chang,et al.  MicroRNA-494 Within an Oncogenic MicroRNA Megacluster Regulates G1/S Transition in Liver Tumorigenesis Through Suppression of Mutated in Colorectal Cancer , 2013, Hepatology.

[9]  Atul Bhatnagar,et al.  Plasma MicroRNA Are Disease Response Biomarkers in Classical Hodgkin Lymphoma , 2013, Clinical Cancer Research.

[10]  Y. Li,et al.  Shear stress activation of nuclear receptor PXR in endothelial detoxification , 2013, Proceedings of the National Academy of Sciences.

[11]  C. Szot,et al.  In vitro angiogenesis induced by tumor-endothelial cell co-culture in bilayered, collagen I hydrogel bioengineered tumors. , 2013, Tissue engineering. Part C, Methods.

[12]  P. Zhou,et al.  Radon-Induced Alterations in Micro-RNA Expression Profiles in Transformed BEAS2B Cells , 2013, Journal of toxicology and environmental health. Part A.

[13]  M. Fung,et al.  Peroxisome Proliferator-Activated Receptor-&ggr; Ameliorates Pulmonary Arterial Hypertension by Inhibiting 5-Hydroxytryptamine 2B Receptor , 2012, Hypertension.

[14]  C. Croce,et al.  MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non–small-cell lung cancer through BIM down-regulation , 2012, Proceedings of the National Academy of Sciences.

[15]  James W. Clancy,et al.  Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers. , 2012, Genes & development.

[16]  Xuetao Cao,et al.  MicroRNA-494 Is Required for the Accumulation and Functions of Tumor-Expanded Myeloid-Derived Suppressor Cells via Targeting of PTEN , 2012, The Journal of Immunology.

[17]  P. Fasanaro,et al.  Deep-sequencing of endothelial cells exposed to hypoxia reveals the complexity of known and novel microRNAs. , 2012, RNA.

[18]  J. Stenvang,et al.  Inhibition of microRNA function by antimiR oligonucleotides , 2012, Silence.

[19]  D. Cheresh,et al.  Tumor angiogenesis: molecular pathways and therapeutic targets , 2011, Nature Medicine.

[20]  F. DiMeco,et al.  Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of cancer stem-like cells. , 2011, Cancer research.

[21]  G. Camussi,et al.  Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. , 2011, Cancer research.

[22]  B. Jiang,et al.  MiR-21 Induced Angiogenesis through AKT and ERK Activation and HIF-1α Expression , 2011, PloS one.

[23]  P Barbry,et al.  miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity , 2011, Cell Death and Differentiation.

[24]  James W. Tung,et al.  Non-Small Cell Lung Cancer Cells Expressing CD44 Are Enriched for Stem Cell-Like Properties , 2010, PloS one.

[25]  C. Sen,et al.  miR-200b Targets Ets-1 and Is Down-regulated by Hypoxia to Induce Angiogenic Response of Endothelial Cells* , 2010, The Journal of Biological Chemistry.

[26]  Sabita Roy,et al.  Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-α isoforms and promotes angiogenesis. , 2010, The Journal of clinical investigation.

[27]  M. Medvedovic,et al.  MicroRNA-494 Targeting Both Proapoptotic and Antiapoptotic Proteins Protects Against Ischemia/Reperfusion-Induced Cardiac Injury , 2010, Circulation.

[28]  Crislyn D'Souza-Schorey,et al.  Microvesicles: mediators of extracellular communication during cancer progression , 2010, Journal of Cell Science.

[29]  Sung-Liang Yu,et al.  MicroRNA-519c suppresses hypoxia-inducible factor-1alpha expression and tumor angiogenesis. , 2010, Cancer research.

[30]  Yiguo Jiang,et al.  Overexpressed miR-494 down-regulates PTEN gene expression in cells transformed by anti-benzo(a)pyrene-trans-7,8-dihydrodiol-9,10-epoxide. , 2010, Life sciences.

[31]  J. Rak,et al.  Microvesicles: Messengers and mediators of tumor progression , 2009, Cell cycle.

[32]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[33]  C. Lee,et al.  MicroRNA and cancer – focus on apoptosis , 2008, Journal of cellular and molecular medicine.

[34]  S. Chien,et al.  Suppression of c-Cbl Tyrosine Phosphorylation Inhibits Neointimal Formation in Balloon-Injured Rat Arteries , 2008, Circulation.

[35]  R. Johnson,et al.  Hypoxia: A key regulator of angiogenesis in cancer , 2007, Cancer and Metastasis Reviews.

[36]  G. Parmiani,et al.  Tumor-released microvesicles as vehicles of immunosuppression. , 2007, Cancer research.

[37]  Qiulian Wu,et al.  Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. , 2006, Cancer research.

[38]  I. Shiojima,et al.  Role of Akt Signaling in Vascular Homeostasis and Angiogenesis , 2002, Circulation research.

[39]  M. Birrer,et al.  c-Jun triggers apoptosis in human vascular endothelial cells. , 1999, Circulation research.

[40]  T. Nagasu,et al.  Inhibition of human tumor xenograft growth by treatment with the farnesyl transferase inhibitor B956. , 1995, Cancer research.